Clinical Trial: Intermittent White Light Stimulation (IWLS) for the Treatment of Major Depressive Disorder: An Open-Label Study of Safety, Tolerability, and Efficacy

U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06922812) titled 'Intermittent White Light Stimulation (IWLS) for the Treatment of Major Depressive Disorder: An Open-Label Study of Safety, Tolerability, and Efficacy' on April 03.

Brief Summary: INTRODUCTION:

Depression is the most common mood disorder worldwide, with approximately 20 million adults affected in the United States in 2019. Current pharmacological treatments are not effective for all patients, often have significant side effects, and in some cases, require medical monitoring. Non-invasive brain stimulation (NIBS) techniques are emerging as a promising therapeutic alternative, offering fewer side effects. In this context, 60 Hz inter...